Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nanolive SA logo — Capture dynamic, unbiased live cell data to accelerate disco...

Nanolive SA

Capture dynamic, unbiased live cell data to accelerate discovery, development and therapeutics.

Founded 2013 Switzerland Switzerland 34 employees Series C Total: $5.40M Biotechnology, VR/AR

General Information

Company Name Nanolive SA
Founded Year 2013
Location Switzerland Switzerland +2
Founders / Decision Makers
Team member
Employees 34
Industries Biotechnology, VR/AR
Funding Stage Series C
Social

Get notified when Nanolive SA moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Major Customer Win Sep 23, 2026

Nanolive SA announced that Università degli Studi di Milano-Bicocca utilized Nanolive's label-free imaging and digital assay for a new paper monitoring neurotoxic effects, demonstrating the platfor…

Event Participation Sep 21, 2026

Nanolive SA will be attending and presenting a live demo at the World Mitochondria Society's Congress in Berlin from October 21st to 23rd, 2026.

Product Launch Sep 08, 2026

Nanolive SA has launched the Smart Lipid Droplet Assay, a new live-cell imaging solution combining high-resolution imaging with AI-powered analysis to provide label-free insights into metabolic res…

New Partnership Sep 08, 2026

Nanolive SA announced a collaboration with Amgen, showcasing a study on lipid droplet accumulation in human pancreas adenocarcinoma cells.

Get alerts when Nanolive SA shows new signals

About Nanolive SA

Nanolive SA, founded in 2013 and headquartered in Switzerland, operates at the forefront of the Biotechnology and VR/AR industries with its pioneering 3D imaging solutions. With a defining slogan, “Capture dynamic, unbiased live cell data to accelerate discovery, development and therapeutics,” the company empowers scientists to uncover novel biological insights, crucial for fields such as drug discovery and cell therapy.

Nanolive's technology radically advances the understanding of living cells, providing insights into complex biological processes, including cancer mechanisms and neurodegenerative diseases. The company secured a $2.20M Series C investment on 01 September 2022, with key investors Innoviva and Taiwania Capital. This financial backing underscores the confidence of notable investors in Nanolive's potential to influence groundbreaking research and therapeutics.

Taxonomy: 3D imaging solutions, Drug discovery, Cell therapy, Live cell imaging, Noninvasive imaging, Label-free imaging, Cancer research, Neurodegenerative diseases, Stem cell research, Metabolic analysis, Mitochondrial studies, Fluorescence imaging, Pharmaceutical research, Real-time cell analysis

Services & Products

Automated Live Cell Imaging
AI-Powered Digital Assays
3D Cell Explorer Platforms
Label-Free Mitochondrial Analysis
Long-term Cell Monitoring

Target Customers

Biotechnology Companies Pharmaceutical Research Labs Oncology Research Institutions Immunology Researchers Cosmetics Research

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 2
Investor
•••• •••• 		01 Sep 2022
Early VC •••••• 2
Investor
•••• •••• 		01 Oct 2016
Growth Equity Vc •••••• 1 •••• •••• 01 Jul 2016
Seed •••••• 1 •••• •••• 01 Feb 2015
Seed •••••• - 01 Nov 2014

View All 6 Funding Rounds

Nanolive SA Alternatives & Competitors

View All Alternatives
Nanolive SA vs
Visikol
Visikol United States

Advanced imaging, digital pathology and 3D cell culture drug discovery services.

Grant
14 employees
Analytics, Biotechnology
Compare Nanolive SA vs Visikol
Nanolive SA vs
TOMOCUBE, INC.
TOMOCUBE, INC. Korea South

See your samples like never before with Tomocube’s revolutionary label-free, live cell Holotomograph...

Series C
57 employees
Biotechnology, Health Care
Compare Nanolive SA vs TOMOCUBE, INC.
Nanolive SA vs
Phase Holographic Imaging
Phase Holographic Imaging Sweden

Discover the full story of your cells. Live cell analysis now is cell-friendly, automatic & right in...

Post Ipo Debt
16 employees
Biotechnology, Privacy and Security
Compare Nanolive SA vs Phase Holographic Imaging
Also compare with: Nanolive SA vs Thrive Bioscience, Inc. Thrive Bioscience, Inc. View all alternatives

FAQ About Nanolive SA

Capture dynamic, unbiased live cell data to accelerate discovery, development and therapeutics.
Nanolive SA was founded in 2013.
Nanolive SA is headquartered in Switzerland.
Nanolive SA operates in the following industries: Biotechnology, VR/AR.
Nanolive SA has approximately 34 employees.
Nanolive SA has completed 6 funding rounds, raising a total of $5.40M. The latest funding stage is Series C.
Nanolive SA offers: Automated Live Cell Imaging, AI-Powered Digital Assays, 3D Cell Explorer Platforms, Label-Free Mitochondrial Analysis, Long-term Cell Monitoring.
Top alternatives and competitors to Nanolive SA include Visikol, TOMOCUBE, INC., Phase Holographic Imaging, Phasefocus, Magnetic Insight, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nanolive SA and Visikol are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nanolive SA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes